<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>RGE-GCN: Recursive Gene Elimination with Graph Convolutional Networks for RNA-seq based Early Cancer Detection - Health AI Hub</title>
    <meta name="description" content="RGE-GCN is a novel framework combining Graph Convolutional Networks (GCNs) for classification with a recursive gene elimination strategy for early cancer detect">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>RGE-GCN: Recursive Gene Elimination with Graph Convolutional Networks for RNA-seq based Early Cancer Detection</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.04333v1" target="_blank">2512.04333v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-03
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Shreyas Shende, Varsha Narayanan, Vishal Fenn, Yiran Huang, Dincer Goksuluk, Gaurav Choudhary, Melih Agraz, Mengjia Xu
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.LG, cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.98 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.04333v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.04333v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">RGE-GCN is a novel framework combining Graph Convolutional Networks (GCNs) for classification with a recursive gene elimination strategy for early cancer detection from RNA-seq data. It effectively identifies a compact set of interpretable and predictive gene biomarkers by outperforming standard tools in accuracy and F1-scores, with selected genes aligning with known cancer pathways.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is crucial for improving cancer patient survival rates by developing a robust, data-driven method for early cancer detection and biomarker discovery from RNA-seq data, overcoming limitations of conventional approaches.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>This research applies Graph Convolutional Networks, a type of Artificial Intelligence, to analyze RNA-seq data for the purpose of early cancer detection and the identification of predictive and interpretable genetic biomarkers. This directly aids in medical diagnostics and personalized treatment strategies.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the challenge of high-dimensional RNA-seq data and complex gene relationships for reliable early cancer biomarker identification.</li>
                    
                    <li>Introduces RGE-GCN, a unified pipeline that integrates feature selection (recursive gene elimination) and classification using Graph Convolutional Networks.</li>
                    
                    <li>Methodology involves building gene expression graphs, classifying cancer vs. normal samples with GCNs, and utilizing Integrated Gradients to score gene importance.</li>
                    
                    <li>Recursively prunes less relevant genes to converge on a compact, highly predictive, and biologically interpretable set of biomarkers.</li>
                    
                    <li>Demonstrated superior performance (higher accuracy and F1-scores) compared to traditional differential expression methods (DESeq2, edgeR, limma-voom) on synthetic and real-world RNA-seq cohorts.</li>
                    
                    <li>Validated on lung, kidney, and cervical cancer datasets, showing consistency across diverse cancer types.</li>
                    
                    <li>Identified genes were biologically significant, aligning with well-known cancer pathways such as PI3K-AKT, MAPK, SUMOylation, and immune regulation.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>RGE-GCN constructs a graph representing gene expression profiles. A Graph Convolutional Network (GCN) is then used for binary classification (cancer vs. normal). Gene importance is assessed via Integrated Gradients. Through an iterative, recursive process, less informative genes are progressively eliminated, leading to a refined and compact set of highly predictive biomarkers.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>RGE-GCN consistently achieved significantly higher accuracy and F1-scores across synthetic and real-world RNA-seq datasets (lung, kidney, cervical cancers) compared to established differential expression tools like DESeq2, edgeR, and limma-voom. Crucially, the genes selected by RGE-GCN were biologically relevant, demonstrating alignment with critical cancer pathways including PI3K-AKT, MAPK, SUMOylation, and immune regulation.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This framework offers a promising, generalizable approach for developing advanced diagnostic tools for early cancer detection. By identifying interpretable and robust gene biomarkers, RGE-GCN could facilitate earlier intervention, improved patient stratification, and contribute to personalized treatment strategies, ultimately enhancing clinical outcomes and survival rates in oncology.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The provided abstract does not explicitly state any specific limitations of the RGE-GCN framework.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>While not explicitly detailed as 'future directions,' the paper concludes by suggesting RGE-GCN's promise as a 'generalizable approach' for RNA-seq based early cancer detection and biomarker discovery, implying further validation and broader application across different cancer types and cohorts as a logical next step.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Cancer Diagnostics</span>
                    
                    <span class="tag">Precision Medicine</span>
                    
                    <span class="tag">Genomics</span>
                    
                    <span class="tag">Computational Biology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">RNA-seq</span>
                    
                    <span class="tag tag-keyword">Early Cancer Detection</span>
                    
                    <span class="tag tag-keyword">Biomarker Discovery</span>
                    
                    <span class="tag tag-keyword">Graph Convolutional Networks</span>
                    
                    <span class="tag tag-keyword">Gene Expression</span>
                    
                    <span class="tag tag-keyword">Feature Selection</span>
                    
                    <span class="tag tag-keyword">Integrated Gradients</span>
                    
                    <span class="tag tag-keyword">Oncology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Early detection of cancer plays a key role in improving survival rates, but identifying reliable biomarkers from RNA-seq data is still a major challenge. The data are high-dimensional, and conventional statistical methods often fail to capture the complex relationships between genes. In this study, we introduce RGE-GCN (Recursive Gene Elimination with Graph Convolutional Networks), a framework that combines feature selection and classification in a single pipeline. Our approach builds a graph from gene expression profiles, uses a Graph Convolutional Network to classify cancer versus normal samples, and applies Integrated Gradients to highlight the most informative genes. By recursively removing less relevant genes, the model converges to a compact set of biomarkers that are both interpretable and predictive. We evaluated RGE-GCN on synthetic data as well as real-world RNA-seq cohorts of lung, kidney, and cervical cancers. Across all datasets, the method consistently achieved higher accuracy and F1-scores than standard tools such as DESeq2, edgeR, and limma-voom. Importantly, the selected genes aligned with well-known cancer pathways including PI3K-AKT, MAPK, SUMOylation, and immune regulation. These results suggest that RGE-GCN shows promise as a generalizable approach for RNA-seq based early cancer detection and biomarker discovery (https://rce-gcn.streamlit.app/ ).</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>12 pages, 2 figures</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>